Clinical Observation of Gefitinib with Pericardial Perfusion for 
Advanced Non-small Cell Lung Cancer

Clinical Observation of Gefitinib with Pericardial Perfusion for 
Advanced Non-small Cell Lung Cancer

Background and objective Epidermal growth factor receptor (EGFR) mutation non-small cell lung cancer (NSCLC) is an important subtype of lung cancer. The incidence of malignant pericardial effusion (MPCE) in EGFR-mutant NSCLC patients is high. However, there are few researches on the treatmentof this...

Full description

Bibliographic Details
Main Authors: Xiaomeng WANG, Jin CHEN, Jiaqi YAO, Renhua GUO
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2018-01-01
Series:Chinese Journal of Lung Cancer
Subjects:
Malignant pericardialeffusion
Gefitinib
Hydroxycamptothecine
Lung neoplasms
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2018.01.10

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2018.01.10

Similar Items